IAG Capital Partners
Venture Capital
Active
Charleston, United States
41
27M
32
8
0.22
- Areas of investment
Summary
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the IAG Capital Partners, startups are often financed by Total Access Fund, The Yard Ventures, Purple Arch Ventures. The meaningful sponsors for the fund in investment in the same round are Next Act Fund, MissionOG, Grotech Ventures.
Among the various public portfolio startups of the fund, we may underline Tethr Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Product Research, Artificial Intelligence.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 41
- Lead investments
- 8
- Follow on index
- 0.22
- Investments by industry
- Health Care (13)
- Artificial Intelligence (12)
- Biotechnology (11)
- Software (10)
- Medical Device (9) Show 51 more
- Investments by region
-
- United States (37)
- United Kingdom (1)
- Germany (1)
- Ireland (1)
- Spain (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 24M
- Group Appearance index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Obsidio | 06 Aug 2020 | Health Care, Medical Device | Seed | 3M | United States, South Carolina, Columbia |
| VenoStent | 31 Jul 2023 | Health Care, Medical Device, Advanced Materials | Early Stage Venture | 16M | United States, Nashville, Tennessee |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.